Startup Clinical Advisory
Clinical leadership, sized for a startup
Fractional clinical advisory and founder office-hours — the credibility and judgement you need, matched to your stage.
How we engage
Flexible, stage-matched support
Founder office-hours
Quick access for clinical and regulatory questions.
Quarterly retainers
Ongoing clinical strategy and review.
Stage mapping
Seed to growth — the right input at the right time.
See also: Health-Tech & AI Startups and AI Validation.
Why founders need this
Clinical credibility is a gate, not a nicety
For a health-tech startup, clinical credibility is not a finishing touch added before launch — it is a gate that determines whether you can raise, sell or even deploy. Investors increasingly run clinical and technical due diligence; NHS buyers expect evidence of clinical safety and governance before a pilot, let alone a contract; and a product designed without clinical input often carries assumptions that become expensive to unpick later. Yet a full-time senior clinical hire is out of reach for most early companies, both in cost and in finding someone willing to take the risk at seed stage.
Fractional clinical advisory bridges that gap. You get senior clinical leadership and judgement on a retained basis, scaled to where you are — light-touch office-hours when you simply need a question answered, deeper involvement when you are preparing a pilot, a funding round or a regulatory step. The aim is to embed clinical thinking into your roadmap and risk profile early, when it is cheap to act on, rather than discovering a problem at the point of an NHS evaluation. This sits within our broader clinical advisory and governance work and complements our focus on health-tech and AI startups.
How an engagement typically unfolds
From first call to ongoing input
- Orient. We map your stage, product and immediate pressures — funding, pilot, regulatory question — and identify where clinical input changes the outcome most.
- Match the cadence. We set the right level of involvement, from periodic office-hours to a quarterly retainer, so you pay for the judgement you need and no more.
- Shape the product. We feed clinical safety, evidence and usability thinking into your roadmap and risk decisions before they harden into the build.
- Prepare the milestones. When a pilot, due diligence or assurance step approaches, we help you ready the clinical evidence and narrative it will be judged on.
Where we help most
The questions founders bring us
- Is our clinical claim defensible, and what evidence will the NHS and investors expect us to show for it?
- Do we need a clinical safety officer or formal clinical risk management yet, and how do those standards apply to us?
- How do we design our first NHS pilot so it actually supports a scale decision — see our pilot design and evaluation work.
- Our product uses AI; how do we evidence that it is safe and validated, drawing on AI validation and clinical safety?
To understand the wider buyer environment your product will enter, our explainer on how the NHS buys digital health is essential reading for any founder targeting the NHS.
Sized to your stage
The right input at the right moment
A seed-stage company and a company entering its first NHS pilot need very different things from a clinical advisor, and a fixed retainer rarely fits either well. Early on, the most useful input is often a few well-timed conversations that stop a founder building in the wrong direction. Later, the need shifts to concentrated work around a specific milestone — a funding round, a regulatory question, a pilot design — where deeper involvement for a defined period earns its cost many times over. We deliberately keep the engagement elastic so it tracks these shifts rather than fighting them.
That flexibility is the point of a fractional model. You are buying senior clinical judgement that flexes up when the stakes rise and settles back when they ease, without the fixed cost and commitment of a full-time leadership hire you may not yet be ready for. As you grow, the same relationship can scale towards a more formal clinical leadership role if that becomes the right step. It connects naturally to the rest of our clinical advisory and governance services and our dedicated focus on health-tech and AI startups.
Answers
Frequently asked questions
What is fractional clinical advisory?
Senior clinical leadership on a part-time, retained basis — the clinical credibility and judgement investors and the NHS expect, without a full-time hire. We scale involvement to your stage.
Do you offer founder office-hours?
Yes — regular office-hours for quick clinical and regulatory questions, plus deeper quarterly strategy sessions.
When should a health-tech startup bring in clinical advisory?
Earlier than most founders expect. Clinical input on the problem definition and risk profile shapes the product before expensive decisions are locked in, and it is far cheaper to design safety and evidence in than to retrofit them ahead of an NHS pilot or a funding round.
Is fractional advisory the same as a clinical safety officer?
No. Fractional advisory provides clinical leadership and judgement across product, evidence and strategy. A clinical safety officer is a defined assurance role under specific NHS standards. We help you understand which you need and when, and how the two relate.
Can you help us prepare for investor due diligence?
Yes. We help founders articulate the clinical rationale, evidence position and risk management that technical and clinical due diligence will probe, so the clinical story stands up to scrutiny rather than becoming the weak point in the round.
Book founder office hours
Tell us your stage and challenge; we'll propose a plan.